Hot Pursuit     31-Jul-23
Rossari Biotech declines after muted Q1 performance
Rossari Biotech slipped 3.44% to Rs 845.40 after the company reported 2% rise in net profit to Rs 29.2 crore as revenues from operations declined by 6% to Rs 410.6 crore in Q1 FY24 as compared with Q1 FY23.

EBITDA remained flat at Rs 57.7 crore while EBITDA margin improved by 80 bps to 14.1% in Q1 FY24 over Q1 FY23.

Profit before tax in Q1 FY24 stood at Rs 43.4 crore, up by 3% from Rs 42.3 crore in Q1 FY23.

Edward Menezes, promoter & executive chairman, and Sunil Chari, promoter & managing director, said: "We have recorded a steady performance during the quarter, demonstrating the resilience and adaptability of our business model amidst a challenging global economic landscape.

Our commitment to sustainable and innovative solutions has kept us in a stable position despite the current subdued demand scenario witnessed in the chemical markets.”

Rossari Biotech is a Speciality-Chemicals manufacturer and offers tailor-made solutions for home, personal care and performance chemicals (HPPC), textile speciality chemicals and animal health and nutrition (AHN). With differentiated product offerings, Rossari caters to an array of applications across FMCG, home care, industrial cleaning, personal care, textile speciality chemicals, performance chemicals, the animal health and nutrition and pet care businesses.

Previous News
  Rossari Biotech consolidated net profit rises 37.75% in the September 2023 quarter
 ( Results - Announcements 21-Oct-23   15:55 )
  Rossari Biotech consolidated net profit rises 26.71% in the September 2021 quarter
 ( Results - Announcements 30-Oct-21   17:32 )
  Rossari Biotech consolidated net profit declines 8.81% in the September 2022 quarter
 ( Results - Announcements 05-Nov-22   16:10 )
  Rossari Biotech to discuss results
 ( Corporate News - 24-Apr-23   10:13 )
  Board of Rossari Biotech recommends final dividend
 ( Corporate News - 29-Apr-24   20:22 )
  Rossari Biotech consolidated net profit rises 33.92% in the December 2023 quarter
 ( Results - Announcements 22-Jan-24   08:12 )
  Rossari Biotech IPO ends with robust subscription
 ( IPO Centre - IPO News 16-Jul-20   11:40 )
  Rossari Biotech commissions its greenfield facility at Dahej
 ( Corporate News - 31-Mar-21   17:50 )
  Board of Rossari Biotech to consider fund raising options
 ( Corporate News - 19-Mar-21   09:27 )
  Board of Rossari Biotech recommends Final Dividend
 ( Corporate News - 21-May-22   12:13 )
  Rossari Biotech consolidated net profit rises 1.88% in the June 2023 quarter
 ( Results - Announcements 29-Jul-23   15:26 )
Other Stories
  Associated Alcohols & Breweries Ltd leads gainers in 'B' group
  15-May-24   12:15
  Oil India edges higher on bonus share issue proposal
  15-May-24   12:14
  ITI Ltd leads gainers in 'A' group
  15-May-24   12:00
  NSE SME Silkflex Polymers (India) lists at decent premium
  15-May-24   11:57
  Balu Forge posts nearly 86% YoY rise in Q4 PAT; EBITDA margin at 21.33%
  15-May-24   11:47
  BSE SME TGIF Agribusiness makes a bumper debut
  15-May-24   11:41
  Apollo Tyres slips as Q4 PAT slides 14% YoY to Rs 354 cr
  15-May-24   11:12
  Volumes soar at V-Mart Retail Ltd counter
  15-May-24   11:00
  Siemens hit life high as Q2 PAT soars 74% YoY; board OKs demerger of Energy biz
  15-May-24   10:34
  TBO Tek spurts on debut
  15-May-24   10:28
Back Top